NVO logo

Novo Nordisk A/S (NVO) Cash from financing

annual CFF:

$1.27B+$10.43B(+113.82%)
December 31, 2024

Summary

  • As of today (August 19, 2025), NVO annual cash flow from financing activities is $1.27 billion, with the most recent change of +$10.43 billion (+113.82%) on December 31, 2024.
  • During the last 3 years, NVO annual CFF has risen by +$5.32 billion (+131.27%).
  • NVO annual CFF is now at all-time high.

Performance

NVO Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

quarterly CFF:

-$3.85B-$1.77B(-84.71%)
June 1, 2025

Summary

  • As of today (August 19, 2025), NVO quarterly cash flow from financing activities is -$3.85 billion, with the most recent change of -$1.77 billion (-84.71%) on June 1, 2025.
  • Over the past year, NVO quarterly CFF has dropped by -$6.29 billion (-258.33%).
  • NVO quarterly CFF is now -171.88% below its all-time high of $5.36 billion, reached on December 31, 2024.

Performance

NVO quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFF:

-$3.27B-$6.29B(-208.26%)
June 1, 2025

Summary

  • As of today (August 19, 2025), NVO TTM cash flow from financing activities is -$3.27 billion, with the most recent change of -$6.29 billion (-208.26%) on June 1, 2025.
  • Over the past year, NVO TTM CFF has increased by +$2.48 billion (+43.14%).
  • NVO TTM CFF is now -208.26% below its all-time high of $3.02 billion, reached on March 31, 2025.

Performance

NVO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NVO Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+113.8%-258.3%+43.1%
3 y3 years+131.3%-164.8%+39.7%
5 y5 years+123.8%-239.7%+39.2%

NVO Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+113.8%-171.9%at low-208.3%+67.4%
5 y5-yearat high+113.8%-171.9%at low-208.3%+67.4%
alltimeall timeat high+113.8%-171.9%at low-208.3%+67.4%

NVO Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$3.85B(+84.7%)
-$3.27B(-208.3%)
Mar 2025
-
-$2.09B(-138.9%)
$3.02B(+138.4%)
Dec 2024
$1.27B(-113.8%)
$5.36B(-299.3%)
$1.27B(-122.8%)
Sep 2024
-
-$2.69B(-210.5%)
-$5.56B(-3.2%)
Jun 2024
-
$2.43B(-163.4%)
-$5.75B(-42.7%)
Mar 2024
-
-$3.84B(+161.6%)
-$10.03B(+9.5%)
Dec 2023
-$9.16B(+25.2%)
-$1.47B(-49.0%)
-$9.16B(+5.6%)
Sep 2023
-
-$2.88B(+55.8%)
-$8.68B(+11.3%)
Jun 2023
-
-$1.85B(-37.9%)
-$7.80B(+5.3%)
Mar 2023
-
-$2.97B(+203.5%)
-$7.40B(+1.2%)
Dec 2022
-$7.32B(+80.6%)
-$979.52M(-51.0%)
-$7.32B(+31.8%)
Sep 2022
-
-$2.00B(+37.2%)
-$5.55B(+2.3%)
Jun 2022
-
-$1.46B(-49.5%)
-$5.43B(+18.1%)
Mar 2022
-
-$2.89B(-466.3%)
-$4.59B(+13.3%)
Dec 2021
-$4.05B(-17.8%)
$787.58M(-142.1%)
-$4.05B(-18.5%)
Sep 2021
-
-$1.87B(+200.6%)
-$4.97B(+4.2%)
Jun 2021
-
-$622.81M(-73.4%)
-$4.77B(-9.7%)
Mar 2021
-
-$2.34B(+1650.3%)
-$5.28B(+7.1%)
Dec 2020
-$4.93B(-7.3%)
-$133.94M(-92.0%)
-$4.93B(-11.2%)
Sep 2020
-
-$1.67B(+47.2%)
-$5.55B(+3.2%)
Jun 2020
-
-$1.13B(-43.0%)
-$5.38B(+2.4%)
Mar 2020
-
-$1.99B(+163.3%)
-$5.25B(-1.2%)
Dec 2019
-$5.32B(-2.6%)
-$756.47M(-49.4%)
-$5.32B(+3.0%)
Sep 2019
-
-$1.50B(+48.2%)
-$5.17B(-3.5%)
Jun 2019
-
-$1.01B(-50.9%)
-$5.36B(+3.2%)
Mar 2019
-
-$2.06B(+241.1%)
-$5.19B(-5.0%)
Dec 2018
-$5.46B(+1.0%)
-$603.29M(-64.2%)
-$5.46B(-3.2%)
Sep 2018
-
-$1.68B(+99.9%)
-$5.65B(-1.9%)
Jun 2018
-
-$842.92M(-63.9%)
-$5.75B(-0.4%)
Mar 2018
-
-$2.33B(+196.6%)
-$5.78B(+6.8%)
Dec 2017
-$5.41B(-6.3%)
-$786.65M(-56.1%)
-$5.41B(+4.0%)
Sep 2017
-
-$1.79B(+106.8%)
-$5.20B(+2.5%)
Jun 2017
-
-$866.27M(-56.0%)
-$5.08B(-2.5%)
Mar 2017
-
-$1.97B(+240.0%)
-$5.21B(-9.9%)
Dec 2016
-$5.78B(+29.1%)
-$578.73M(-65.2%)
-$5.78B(-0.4%)
Sep 2016
-
-$1.67B(+67.2%)
-$5.80B(+18.0%)
Jun 2016
-
-$995.91M(-60.8%)
-$4.92B(+1.5%)
Mar 2016
-
-$2.54B(+319.6%)
-$4.85B(+8.3%)
Dec 2015
-$4.48B(-5.2%)
-$604.80M(-22.5%)
-$4.48B(+0.1%)
Sep 2015
-
-$779.96M(-15.5%)
-$4.47B(+2.2%)
Jun 2015
-
-$922.92M(-57.4%)
-$4.38B(-2.1%)
Mar 2015
-
-$2.17B(+260.6%)
-$4.47B(-5.3%)
Dec 2014
-$4.72B(+12.2%)
-$601.03M(-12.2%)
-$4.72B(+0.7%)
Sep 2014
-
-$684.25M(-32.7%)
-$4.69B(+3.9%)
Jun 2014
-
-$1.02B(-58.0%)
-$4.51B(-4.1%)
Mar 2014
-
-$2.42B(+325.3%)
-$4.71B(+11.8%)
Dec 2013
-$4.21B(+21.1%)
-$568.88M(+12.0%)
-$4.21B(+7.0%)
Sep 2013
-
-$507.77M(-58.0%)
-$3.93B(+5.2%)
Jun 2013
-
-$1.21B(-37.1%)
-$3.74B(+5.8%)
Mar 2013
-
-$1.92B(+553.2%)
-$3.53B(+1.7%)
Dec 2012
-$3.48B(+10.8%)
-$294.26M(-6.0%)
-$3.48B(-6.7%)
Sep 2012
-
-$313.00M(-68.8%)
-$3.72B(-13.7%)
Jun 2012
-
-$1.00B(-46.1%)
-$4.32B(+16.1%)
Mar 2012
-
-$1.86B(+243.0%)
-$3.72B(+18.5%)
Dec 2011
-$3.14B
-$543.28M(-40.0%)
-$3.14B(+9.9%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$904.87M(+123.1%)
-$2.85B(+5.9%)
Jun 2011
-
-$405.52M(-68.4%)
-$2.70B(+3.5%)
Mar 2011
-
-$1.28B(+390.3%)
-$2.60B(+10.8%)
Dec 2010
-$2.35B(+25.2%)
-$261.61M(-64.9%)
-$2.35B(-2.4%)
Sep 2010
-
-$745.40M(+137.9%)
-$2.41B(+10.9%)
Jun 2010
-
-$313.37M(-69.5%)
-$2.17B(+2.3%)
Mar 2010
-
-$1.03B(+222.9%)
-$2.12B(+13.0%)
Dec 2009
-$1.88B(+29.7%)
-$318.61M(-37.4%)
-$1.88B(+7.1%)
Sep 2009
-
-$508.59M(+92.5%)
-$1.75B(+7.6%)
Jun 2009
-
-$264.23M(-66.3%)
-$1.63B(+4.7%)
Mar 2009
-
-$784.28M(+304.7%)
-$1.55B(+7.4%)
Dec 2008
-$1.45B(+15.2%)
-$193.77M(-49.6%)
-$1.45B(-12.5%)
Sep 2008
-
-$384.30M(+101.1%)
-$1.65B(-5.3%)
Jun 2008
-
-$191.07M(-71.8%)
-$1.74B(+11.7%)
Mar 2008
-
-$677.27M(+69.1%)
-$1.56B(+24.4%)
Dec 2007
-$1.26B(+56.8%)
-$400.52M(-15.9%)
-$1.26B(+47.3%)
Sep 2007
-
-$475.97M(+6099.4%)
-$852.47M(+10.2%)
Jun 2007
-
-$7.68M(-97.9%)
-$773.49M(-3.7%)
Mar 2007
-
-$371.18M(<-9900.0%)
-$803.36M(+0.3%)
Dec 2006
-$800.66M(+8.3%)
$2.36M(-100.6%)
-$800.66M(-3.9%)
Sep 2006
-
-$397.00M(+957.3%)
-$833.07M(+41.1%)
Jun 2006
-
-$37.55M(-89.8%)
-$590.33M(-25.2%)
Mar 2006
-
-$368.47M(+1126.3%)
-$789.31M(+6.8%)
Dec 2005
-$739.23M(+28.2%)
-$30.05M(-80.5%)
-$739.23M(-9.7%)
Sep 2005
-
-$154.26M(-34.8%)
-$818.19M(+6.5%)
Jun 2005
-
-$236.52M(-25.7%)
-$768.46M(+29.9%)
Mar 2005
-
-$318.40M(+192.1%)
-$591.53M(+2.6%)
Dec 2004
-$576.43M(+58.3%)
-$109.00M(+4.3%)
-$576.43M(+23.3%)
Sep 2004
-
-$104.54M(+75.4%)
-$467.42M(+28.8%)
Jun 2004
-
-$59.59M(-80.4%)
-$362.88M(+19.6%)
Mar 2004
-
-$303.29M
-$303.29M
Dec 2003
-$364.11M(+88.0%)
-
-
Dec 2002
-$193.65M(+70.7%)
-
-
Dec 2001
-$113.44M(-57.3%)
-
-
Dec 2000
-$265.87M(+2410.5%)
-
-
Dec 1999
-$10.59M(-97.4%)
-
-
Dec 1998
-$399.94M(-613.0%)
-
-
Dec 1997
$77.97M(-161.7%)
-
-
Dec 1996
-$126.43M(-59.5%)
-
-
Dec 1995
-$312.48M(-370.2%)
-
-
Dec 1994
$115.66M(+125.2%)
-
-
Dec 1993
$51.35M(-20.7%)
-
-
Dec 1992
$64.74M(-76.7%)
-
-
Dec 1991
$277.77M(-909.7%)
-
-
Dec 1990
-$34.31M(-224.6%)
-
-
Dec 1989
$27.53M(+128.8%)
-
-
Dec 1988
$12.03M(-180.9%)
-
-
Dec 1987
-$14.88M(+18.0%)
-
-
Dec 1986
-$12.61M(+30.9%)
-
-
Dec 1985
-$9.64M(-1.5%)
-
-
Dec 1984
-$9.78M(-10.7%)
-
-
Dec 1983
-$10.96M(+18.1%)
-
-
Dec 1982
-$9.27M(-2.6%)
-
-
Dec 1981
-$9.52M(+37.4%)
-
-
Dec 1980
-$6.92M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash flow from financing activities?
  • What is the all time high annual CFF for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual CFF year-on-year change?
  • What is Novo Nordisk A/S quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly CFF year-on-year change?
  • What is Novo Nordisk A/S TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM CFF year-on-year change?

What is Novo Nordisk A/S annual cash flow from financing activities?

The current annual CFF of NVO is $1.27B

What is the all time high annual CFF for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash flow from financing activities is $1.27B

What is Novo Nordisk A/S annual CFF year-on-year change?

Over the past year, NVO annual cash flow from financing activities has changed by +$10.43B (+113.82%)

What is Novo Nordisk A/S quarterly cash flow from financing activities?

The current quarterly CFF of NVO is -$3.85B

What is the all time high quarterly CFF for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash flow from financing activities is $5.36B

What is Novo Nordisk A/S quarterly CFF year-on-year change?

Over the past year, NVO quarterly cash flow from financing activities has changed by -$6.29B (-258.33%)

What is Novo Nordisk A/S TTM cash flow from financing activities?

The current TTM CFF of NVO is -$3.27B

What is the all time high TTM CFF for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash flow from financing activities is $3.02B

What is Novo Nordisk A/S TTM CFF year-on-year change?

Over the past year, NVO TTM cash flow from financing activities has changed by +$2.48B (+43.14%)
On this page